UAE pharma market developing and local capacity increasing

19 November 2010

The United Arab Emirates (UAE) has started to make strides on the global pharmaceutical map. Although the drug industry is still in its nascent stage in the country, it is the high per capita drugs consumption that has attracted a number of pharma companies to invest in UAE, notes a news report added to the offering of Research and Markets.

Moreover, the government is promoting its domestic pharmaceutical industry as a major emerging force in the Gulf and Arab markets. These efforts are likely to take the UAE’s domestic drugs industry to the next level, where it can compete with the foreign participants in the gulf and African region markets.

Estimated $1 billion market

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight



More Features in Pharmaceutical